SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-15-239534
Filing Date
2015-06-29
Accepted
2015-06-29 17:19:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d948209dsc13d.htm SC 13D 68443
  Complete submission text file 0001193125-15-239534.txt   70172
Mailing Address 27200 WEST AGOURA ROAD SUITE 200 CALABASAS CA 91301
Business Address 27200 WEST AGOURA ROAD SUITE 200 CALABASAS CA 91301 818-587-4500
KYTHERA BIOPHARMACEUTICALS INC (Subject) CIK: 0001436304 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87021 | Film No.: 15959248
SIC: 2834 Pharmaceutical Preparations

Mailing Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2
Business Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2 (216) 523-5000
Allergan plc (Filed by) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations